Primary source: Health Canada
Health Canada issued a recall alert for Wyze Solar Cam Pan (model WYZESCPWH) due to burn and fire hazards from incorrect assembly instructions.
The defect poses immediate fire/burn risk from lithium-ion battery overheating. 321,360 units sold in US with reported injuries.
Immediately stop use; visit Wyze Labs website for refund process. Report incidents to Health Canada.
Regulatory Intelligence Lead
as needed
Immediately stop using the recalled product and visit the Wyze Labs Inc. website for the company’s refund process.
Immediately stop use; visit Wyze Labs website for refund process. Report incidents to Health Canada.
Wyze Solar Cam Pan outdoor security camera recalled in Canada and US because incorrect assembly instructions may lead to battery puncture and overheating, causing fire or burn injuries. 12 US incidents, 5 burn injuries reported. 2,562 units sold in Canada.
What changed: Health Canada issued a recall alert for Wyze Solar Cam Pan (model WYZESCPWH) due to burn and fire hazards from incorrect assembly instructions.
Why it matters: The defect poses immediate fire/burn risk from lithium-ion battery overheating. 321,360 units sold in US with reported injuries.
Practical implication: Immediately stop use; visit Wyze Labs website for refund process. Report incidents to Health Canada.
Published from the Firecrawl agent regulatory extraction pipeline.
Implement a gap analysis for 505(b)(2) applications to identify safety data needs and adjust safety monitoring systems as necessary to accommodate new product characteristics.
MAHs and sponsors must enhance their pharmacovigilance systems to monitor microbiome-specific safety issues, comply with established safety standards, and address concerns related to antimicrobial resistance.
Stakeholders, including manufacturers and clinicians, must review and potentially revise their post-market vigilance and safety monitoring protocols in response to the FDA's proposed regulatory approaches for generative AI devices.
Developers of MBMPs must align their safety assessment protocols with the MHRA's expectations and are encouraged to engage with the MHRA early to establish appropriate regulatory strategies.
